January 2, 2018 / 1:46 PM / in 13 minutes BRIEF-Progenics Pharmaceuticals Completes Enrollment In Phase 3 Study Of Psma-Targeted Imaging Agent 1404 Reuters Staff 
Jan 2 (Reuters) - Progenics Pharmaceuticals Inc: * PROGENICS PHARMACEUTICALS INC - 
* PROGENICS PHARMACEUTICALS COMPLETES ENROLLMENT IN PHASE 3 STUDY OF PSMA-TARGETED IMAGING AGENT 1404 Source text for Eikon: Further company coverage: